Embryonic and Fetal Myogenic Programs Act through Separate Enhancers at the MLC1F/3F Locus

Abstract

Embryonic and fetal stages of skeletal muscle development are characterized by the differential expression of a number of muscle-specific genes. These include the products of independent promoters at the fast myosin light chain 1F/3F locus. In the mouse embryo MLC1F transcripts accumulate in embryonic skeletal muscle from E9, 4–5 days before high-level accumulation of MLC3F transcripts. A 3′ enhancer can activate MLC1F and MLC3F promoters in differentiated muscle cellsin vitroand in transgenic mice; both promoters, however, are activated at the time of MLC1F transcript accumulation. We now demonstrate the presence of a second muscle-specific enhancer at this locus, located in the intron separating the MLC1F and MLC3F promoters. Transgenic mice containing the intronic, but lacking the 3′ enhancer, express high levels of annlacZreporter gene from the MLC3F promoter in adult fast skeletal muscle fibers. In contrast to the 3′ enhancer, the intronic element is inactive both in embryonic muscle cellsin vivoand in embryonic myocyte cultures. The intronic enhancer is activated at the onset of fetal development in both primary and secondary muscle fibers, at the time of endogenous MLC3F transcript accumulation. Late-activated MLC3F transgenes thus provide a novelin totomarker of fetal myogenesis. These results suggest that temporal regulation of transcription at the MLC1F/3F locus is controlled by separate enhancers which are differentially activated during embryonic and fetal development.